Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer

[1]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[2]  Yongqiang Wang,et al.  Cuproptosis: a new form of programmed cell death , 2022, Cellular & Molecular Immunology.

[3]  Yuting He,et al.  MIR4435-2HG: A newly proposed lncRNA in human cancer. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  T. Golub,et al.  Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.

[5]  J. Howard,et al.  Patterns in the Management of Low-Grade Non-Muscle-Invasive Bladder Cancer-the Human and Economic Costs of Excessive Surveillance. , 2022, JAMA network open.

[6]  Zhuojun Zheng,et al.  DesA Prognostic Risk Model of LncRNAs in Patients With Acute Myeloid Leukaemia Based on TCGA Data , 2022, Frontiers in Bioengineering and Biotechnology.

[7]  Jiajin Wu,et al.  Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer , 2022, Frontiers in Immunology.

[8]  Shaoli Zhang,et al.  Clinical Potential of lncRNA PPP1R26-AS1 in Breast Cancer and Its Contribution to Cancer Progression , 2022, Molecular Biotechnology.

[9]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[10]  G. Sonpavde,et al.  Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer , 2021, Journal for ImmunoTherapy of Cancer.

[11]  Miaolong Lu,et al.  N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer , 2021, EPMA Journal.

[12]  Haishan Huang,et al.  Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion , 2021, Oncogene.

[13]  Zhi-wei Wang,et al.  The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy , 2021, Molecular cancer.

[14]  Liang Wang,et al.  Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis , 2021, Frontiers in Oncology.

[15]  A. Elorza,et al.  Role of Copper on Mitochondrial Function and Metabolism , 2021, Frontiers in Molecular Biosciences.

[16]  Guoqing Yang,et al.  lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway. , 2021, The international journal of biochemistry & cell biology.

[17]  C. Maher,et al.  Long noncoding RNAs in cancer metastasis , 2021, Nature Reviews Cancer.

[18]  G. De Velasco,et al.  Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future. , 2021, Cancer treatment reviews.

[19]  Qiong Zhang,et al.  Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response , 2020, Briefings Bioinform..

[20]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[21]  N. Agarwal,et al.  Advances in bladder cancer biology and therapy , 2020, Nature Reviews Cancer.

[22]  M. Petris,et al.  Copper metabolism as a unique vulnerability in cancer. , 2020, Biochimica et biophysica acta. Molecular cell research.

[23]  L. Sancey,et al.  The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy , 2020, Cancers.

[24]  Philippe P Roux,et al.  Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer , 2020, Nature Communications.

[25]  Yuchen Liu,et al.  Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer , 2020, Journal of experimental & clinical cancer research : CR.

[26]  Yueqin Li.  Copper homeostasis: Emerging target for cancer treatment. , 2020, IUBMB life.

[27]  Liuqing Yang,et al.  Long noncoding RNA loss in immune suppression in cancer. , 2020, Pharmacology & therapeutics.

[28]  M. Gao,et al.  LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis , 2020, Cancer Cell International.

[29]  Zhicong Chen,et al.  Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2 , 2020, Molecular Cancer.

[30]  J. Wang-Rodriguez,et al.  The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma , 2019, Cancers.

[31]  Mauro A. A. Castro,et al.  Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis , 2019, Genome Medicine.

[32]  R. Flippot,et al.  Long non-coding RNAs in genitourinary malignancies: a whole new world , 2019, Nature Reviews Urology.

[33]  D. Tong,et al.  The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a , 2019, Cellular & Molecular Biology Letters.

[34]  L. Cai,et al.  Serum copper and zinc levels and the risk of oral cancer: A new insight based on large-scale case-control study. , 2018, Oral diseases.

[35]  Yair Lotan,et al.  Bladder cancer , 2020, Nature Reviews Disease Primers.

[36]  A. Belfiore,et al.  Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer , 2017, Molecular and Cellular Endocrinology.

[37]  Yanyan Ping,et al.  Oncogenic long noncoding RNA landscape in breast cancer , 2017, Molecular Cancer.

[38]  Ruimin Huang,et al.  TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer , 2017, Theranostics.

[39]  A. Tjønneland,et al.  Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort , 2017, Carcinogenesis.

[40]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[41]  F. Aksoy,et al.  Changes in the Serum Levels of Trace Elements Before and After the Operation in Thyroid Cancer Patients , 2016, Biological Trace Element Research.

[42]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[43]  Juancarlos Chan,et al.  Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..

[44]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[45]  D. Hanahan,et al.  Bioavailable copper modulates oxidative phosphorylation and growth of tumors , 2013, Proceedings of the National Academy of Sciences.

[46]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[47]  S. Gupta,et al.  Serum and tissue trace elements in colorectal cancer , 1993, Journal of surgical oncology.